| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 05/03/2006 | EP1364040B1 Degradation of epothilones and ethynyl substituted epothilones |
| 05/03/2006 | EP1351954B1 Farnesyl transferase inhibiting 4-heterocyclyl-quinoline and quinazoline derivatives |
| 05/03/2006 | EP1248771B1 Method for preparing hydroxypicolinic acid derivatives |
| 05/03/2006 | EP1242400B1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 05/03/2006 | EP1208091B1 Benzophenones as inhibitors of reverse transcriptase |
| 05/03/2006 | EP1188755B1 Acylhydrazine derivatives, process for preparing the same and use thereof |
| 05/03/2006 | EP1133489B9 Isonipecotamides for the treatment of integrin-mediated disorders |
| 05/03/2006 | EP0937069B1 Piperazino derivatives as neurokinin antagonists |
| 05/03/2006 | EP0672042B1 Pharmacologically active pyrimidineamine derivatives and processes for the preparation thereof |
| 05/03/2006 | CN1768057A Process for preparing a polymorph of rosiglitazone maleate |
| 05/03/2006 | CN1768054A Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 05/03/2006 | CN1254474C Tetrahydroazepine derivatives useful as dopamine d3 receptor modulators (antipsychotic agents) |
| 05/03/2006 | CA2524869A1 New benzothiadiazine derivatives, their preparation process and the pharmaceutical compounds that contain them |
| 05/02/2006 | US7037929 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/02/2006 | US7037926 Anticarcinogenic, antiallergen, and antiinflammatory agents; autoimmuned diseases |
| 05/02/2006 | US7037925 for treating or preventing organ transplant rejection, lupus, multiple sclerosis, rheumatoid arthritis, psoriasis, Type I diabetes, asthma, rhinitis, atopic dermatitis, autoimmune disorders, Alzheimer's disease, leukemia |
| 05/02/2006 | US7037918 Antidiabetic agents, cardiovascular disorders, Alzheimer's disease, nervous system disorders |
| 05/02/2006 | US7037914 Carboxylic acid derivative and a pharmaceutical composition containing the derivative as active ingredient |
| 05/02/2006 | US7037908 HIV integrase inhibitors |
| 05/02/2006 | US7037880 Ethylene derivatives and pesticides containing said derivatives |
| 05/02/2006 | CA2326804C Compounds with activity on muscarinic receptors |
| 04/27/2006 | WO2006044955A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | WO2006044825A2 Mitotic kinesin inhibitors and methods of use thereof |
| 04/27/2006 | WO2006044457A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/27/2006 | WO2006044454A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | WO2006044228A1 Histamine h3 receptor inhibitors, preparation and therapeutic uses |
| 04/27/2006 | WO2006043691A1 Target protein and target gene in drug designing and screening method |
| 04/27/2006 | WO2006043655A1 Medicinal composition for inhalation |
| 04/27/2006 | WO2006043490A1 Pyrimidine derivative fused with nonaromatic ring |
| 04/27/2006 | WO2006042954A1 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof |
| 04/27/2006 | WO2006019957A3 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
| 04/27/2006 | WO2006014290A3 Anti-inflammatory medicaments |
| 04/27/2006 | WO2006011157A3 Methods for the preparation of aryl piperazinyl-heterocyclic compounds |
| 04/27/2006 | WO2005101989A3 Piperidine derivatives as modulators of chemokine receptor ccr5 |
| 04/27/2006 | US20060089502 condensing mixture of 5-(2-chloroethyl)-6-chlorooxindole, 5-(2-chloroacetyl)-6-chloro-2-oxindole, and 5-(2-chlorohydroxylethyl)-6-chlorooxindole with 3-(1-piperazinyl)-1,2-benzisothiazole to form mixture of ziprasidone and impurities, and purifying ziprasidone by slurrying, recrystallization |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089382 Substituted 3-cyanoquinolines as mek inhibitors |
| 04/27/2006 | US20060089380 Treating nervous system disorders such as mild cognitive impairment, Alzheimer's disease or dementia associated with Down syndrome; e.g. use of 5,7-dichloro-8-hydroxy-2-(2-pyridyl)-quinoline (PBT 1052) |
| 04/27/2006 | US20060089366 New piperazine and piperidine compounds |
| 04/27/2006 | US20060089364 Arylpiperaszine derivatives, to the process for the production thereof and to the use thereof as therapeutic agents |
| 04/27/2006 | US20060089363 Antibacterial agents |
| 04/27/2006 | US20060089354 ligands for receptor localization studies; for inhibiting binding of vanilloid ligand to a capsaicin receptor; Phosphoric acid dibenzyl ester 4-(4-tert-butyl-phenylamino)-7-(3-trifluoromethyl-pyridin-2-yl)-quinazolin-2-ylmethyl ester; to treat neuropathic pain, itch, urinary incontinence, cough, obesity |
| 04/27/2006 | US20060089352 Substituted thiazines as material protecting agents |
| 04/27/2006 | US20060089351 Neuropeptide receptor modulators |
| 04/27/2006 | US20060089346 Optionally fused aryl-substituted azepanones, oxazepanone or thiazepanones substituted with a dipeptide group, e.g., N2-[(3,5-difluorophenyl)acetyl]-N1-[(2R,3R)-2-(2,5-difluorophenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl]-L-alaninamide; secretase inhibitors for treating Alzheimer's disease |
| 04/27/2006 | US20060089345 Indole derivatives, method for preparating same and pharmaceutical compositions containing same |
| 04/27/2006 | US20060089344 E.g., 2-(Methylamino)-2-oxoethyl 3-[1-(1-isoquinolyl)-4-piperidyl]propylcarbamate hydrochloride and 3{2-[1-(2-quinolyl)-4-piperidyl]-ethyl}-1,3-oxazolidine-2,4-dione; preventing or treating a pathology in which endogenous cannabinoids and/or any other substrate metabolized by the enzyme FA; analgesics |
| 04/27/2006 | US20060089262 Substituted (thioxo)carbonylamino phenyl uraciles |
| 04/27/2006 | CA2584866A1 Mitotic kinesin inhibitors and methods of use thereof |
| 04/27/2006 | CA2584774A1 2-amido-4-phenylthiazole derivatives, the preparation and the therapeutic use thereof |
| 04/27/2006 | CA2584422A1 1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists |
| 04/27/2006 | CA2584328A1 Phosphodiesterase 4 inhibitors |
| 04/27/2006 | CA2580913A1 N-benzenesulfonyl substituted anilino-pyrimidine analogs |
| 04/26/2006 | EP1650203A1 Process of preparation of benzimidazol-2-yl quinolinone derivatives |
| 04/26/2006 | EP1650201A1 Benzoxazepine compound |
| 04/26/2006 | EP1650192A1 Quinolone derivative or salt thereof |
| 04/26/2006 | EP1648898A1 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 04/26/2006 | EP1648892A2 Aryl-substituted benzo[d]isothiazol-3-ylamine analogues as capsaicin receptor modulators |
| 04/26/2006 | EP1648887A1 Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors |
| 04/26/2006 | EP1648882A1 3-fluoro-piperidines as nmda/nr2b antagonists |
| 04/26/2006 | EP1648879A1 Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain |
| 04/26/2006 | EP1648878A1 Piperidine compounds and pharmaceutical compositions containing them |
| 04/26/2006 | EP1648876A1 5-ht sb 2b /sb receptor antagonists |
| 04/26/2006 | EP1648564A1 Cyanoamide compounds useful as malonyl-coa decarboxylase inhibitors |
| 04/26/2006 | EP1648457A2 Piperidine derivatives as melanocortin-4 receptor agonists |
| 04/26/2006 | EP1648452A1 2-imino-4-(thio)oxo-5-polycyclovinylazolines for use as pi3 kinase inhibitors |
| 04/26/2006 | EP1648448A1 Chemical compounds |
| 04/26/2006 | EP1648447A1 Pyrazolines as par-1 antagonists for treatment of cardiovascular diseases |
| 04/26/2006 | EP1648445A1 Indol-5-yl sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 04/26/2006 | EP1453817B1 Thiazole derivatives with fungicidal activity |
| 04/26/2006 | EP1414802B1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 04/26/2006 | EP1379520B1 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists |
| 04/26/2006 | CN1764661A Benzenesulphonamide derivatives, method for production and use thereof for treatment of pain. |
| 04/26/2006 | CN1764655A Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 04/26/2006 | CN1764651A Quinazoline derivatives as antitumor agents |
| 04/26/2006 | CN1764650A 2, 3, 6-trisubstituted-4-pyrimidone derivatives |
| 04/26/2006 | CN1764641A Viral polymerase inhibitors |
| 04/26/2006 | CN1764454A Cyclic protein tyrosine kinase inhibitors |
| 04/26/2006 | CN1764380A N-phenyl- (4-pyridyl)- azinyl!amine derivatives as plant protection agents. |
| 04/26/2006 | CN1763035A Oligothiophene-arylene derivatives and organic thin film transistors using the same |
| 04/26/2006 | CN1763018A Oxazolidinone analog compound |
| 04/26/2006 | CN1253451C Novel indodyl oxazole compound and its preparation and application |
| 04/26/2006 | CN1253442C Novel thiazine or pyrazine derivatives |
| 04/26/2006 | CN1253441C Protease inhibitors |
| 04/25/2006 | US7034057 Controlling tumor necrosis factor; antiinflamamtory agents, autoimmune disease |
| 04/25/2006 | US7034049 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 04/25/2006 | US7034047 Triazole derivative |
| 04/25/2006 | US7034043 Cell adhesion inhibitors |
| 04/25/2006 | US7034039 Fused heterocyclic compounds |
| 04/25/2006 | US7034035 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 04/25/2006 | US7034033 Substituted quinazolinone compounds |
| 04/25/2006 | US7034029 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
| 04/25/2006 | US7034025 Administering to a mammal an effective dose of a cysteine derivatives containing heteroaromatic group for the treatment of arterial tension, embryogenesis, oncogenesis, diabetes, cell proliferation, and other diseases |
| 04/25/2006 | US7034021 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 04/25/2006 | CA2167291C Substituted 2-phenylpyridines with herbicidal action |
| 04/20/2006 | WO2006042150A1 Diaminoalkane aspartic protease inhibitors |
| 04/20/2006 | WO2006040646A1 Benzimidazole or indole amides as inhibitors of pin1 |
| 04/20/2006 | WO2006040625A1 Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation |
| 04/20/2006 | WO2006040526A1 Quinazoline derivatives for use against cancer |
| 04/20/2006 | WO2006040318A2 Pi3 kinase gamma inhibitors for the treatment of anaemia |